Lv71
4745 积分 2021-03-29 加入
Generation and Characterization of a Bispecific Antibody Targeting Both PD-1 and c-MET
1小时前
待确认
FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development
16天前
已完结
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor–Amplified Gastroesophageal Cancer: Retrospective Global Experience
1个月前
已完结
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
2个月前
已完结
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
2个月前
已完结
Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody–Drug Conjugate
2个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
3个月前
已完结
Fibroblast growth factor 22
5个月前
已完结
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
5个月前
已完结
ADCC enhancement: A conundrum or a boon to mAb therapy?
5个月前
已完结
皖公网安备34019202002308
